| 000 | 02716 a2200745 4500 | ||
|---|---|---|---|
| 005 | 20250516100626.0 | ||
| 264 | 0 | _c20130115 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1098-1136 | ||
| 024 | 7 |
_a10.1002/glia.22374 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuardia Clausi, Mariano | |
| 245 | 0 | 0 |
_aIntranasal administration of aTf protects and repairs the neonatal white matter after a cerebral hypoxic-ischemic event. _h[electronic resource] |
| 260 |
_bGlia _cOct 2012 |
||
| 300 |
_a1540-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a2',3'-Cyclic Nucleotide 3'-Phosphodiesterase _xgenetics |
| 650 | 0 | 4 | _aAdministration, Intranasal |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aAntigens _xmetabolism |
| 650 | 0 | 4 |
_aApoproteins _xadministration & dosage |
| 650 | 0 | 4 | _aAutophagy-Related Proteins |
| 650 | 0 | 4 |
_aBrain Injuries _xetiology |
| 650 | 0 | 4 |
_aBromodeoxyuridine _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCerebral Cortex _xcytology |
| 650 | 0 | 4 |
_aColchicine _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Callosum _xdrug effects |
| 650 | 0 | 4 |
_aCytochalasin B _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 |
_aGreen Fluorescent Proteins _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoxia _xdrug therapy |
| 650 | 0 | 4 |
_aHypoxia-Ischemia, Brain _xcomplications |
| 650 | 0 | 4 |
_aIntermediate Filament Proteins _xmetabolism |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aLateral Ventricles _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aMyelin Basic Protein _xmetabolism |
| 650 | 0 | 4 |
_aNerve Fibers, Myelinated _xdrug effects |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xmetabolism |
| 650 | 0 | 4 | _aNestin |
| 650 | 0 | 4 |
_aNeurogenesis _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aOligodendroglia _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet-Derived Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aProteoglycans _xmetabolism |
| 650 | 0 | 4 |
_aSOXB1 Transcription Factors _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTransferrin _xadministration & dosage |
| 700 | 1 | _aPaez, Pablo M | |
| 700 | 1 | _aCampagnoni, Anthony T | |
| 700 | 1 | _aPasquini, Laura A | |
| 700 | 1 | _aPasquini, Juana M | |
| 773 | 0 |
_tGlia _gvol. 60 _gno. 10 _gp. 1540-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/glia.22374 _zAvailable from publisher's website |
| 999 |
_c21897439 _d21897439 |
||